The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCropper (J) Regulatory News (CRPR)

Share Price Information for Cropper (J) (CRPR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 345.00
Bid: 330.00
Ask: 360.00
Change: 0.00 (0.00%)
Spread: 30.00 (9.091%)
Open: 345.00
High: 345.00
Low: 345.00
Prev. Close: 345.00
CRPR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

8 Mar 2021 07:00

RNS Number : 4015R
Cropper(James) PLC
08 March 2021
 

Cropper(James) PLC

 

8 March 2021

James Cropper plc ("James Cropper" or the "Company")

Trading update

 

James Cropper PLC, the advanced materials and paper products group, is pleased to issue a positive trading update for the 52 weeks to 27 March 2021.

As reported in the half year results to 26 September 2020, the first half of the year had been particularly challenging due to the significant impact of the Covid-19 pandemic. The Group responded quickly to the challenges taking swift action to protect staff, reduce costs, optimise cash flow and protect liquidity. All divisions of the Group were affected to varying degrees by the pandemic. Since the half year, trading has improved, and the restructuring program is now complete.

In January 2021, the TFP division acquired PV3 Technologies Limited, a company specialising in the development and manufacture of electrochemical materials used in the creation of hydrogen. The acquisition is the latest step in TFP's growth plans, providing the opportunity to further enhance TFP's market position in the hydrogen economy. Following the suspension of all major capital expenditure in H1 due to the pandemic, work on installing the additional production line has now recommenced and is expected to be complete in summer of 2021.

Colourform's rate of growth has been impacted by a pandemic related downturn within the beauty and spirit sectors. Nonetheless, it is expected that revenues will be up on the previous year.

The Paper division endured the biggest impact from the pandemic as a result of global lockdowns affecting demand for luxury packaging, education and event collateral. In the first half, revenues were 45% down, compared to the comparable period last year, with the reduced demand leading to periods of inefficient or no production. Revenues in H2 have improved but expected to be 20% down compared to the comparable period last year.

The Company acted promptly at the start of the pandemic to conserve cash and implement immediate savings. It has good headroom against all its banking covenants and is in a strong financial position with liquidity of over £18 million from cash, overdraft and other available facilities including a £4m loan from the Coronavirus Large Business Interruption Loan Scheme. This is expected to be sufficient for the Company to return to more normal trading conditions, to invest and to emerge from the pandemic stronger.

Due to the improving trading performance and continued operational focus the Board expects the results for the year ending 27 March 2021 to be improved from previous expectations. The profit for the year ending 27 March 2021, before exceptional costs, is expected to be above £3.5m on sales of around £77m. This is an improvement from previous market expectations and includes around £2.9m of the Coronavirus Job Retention Scheme and Paycheck Protection Program government schemes.

This announcement contains information that would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

 

 

For further enquiries, please contact:

James Cropper PLC (AIM: CRPR)

Phil Wild, CEO

Isabelle Maddock, CFO

Tel: +44 (0) 1539 722002

www.jamescropper.com

 

 

Shore Capital

Robert Finlay, Henry Willcocks

John More

Tel: + 44 (0) 207 408 4050

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDKPBDCBKDCNK
Date   Source Headline
30th Apr 20247:00 amRNSFull Year Trading Update
12th Mar 20243:06 pmRNSDirector/PDMR Shareholding
8th Mar 20242:25 pmRNSDirector/PDMR Shareholding
17th Jan 20247:00 amRNSTrading Update
12th Jan 20247:00 amRNSDirectorate Update
21st Dec 20233:33 pmRNSDirector/PDMR Shareholding
20th Dec 20237:00 amRNSGrant of Awards under Long Term Incentive Plan
27th Nov 20237:00 amRNSBoard Appointment
24th Nov 20232:30 pmRNSDirectorate Change
9th Nov 20237:00 amRNSInterim Results
26th Oct 20237:00 amRNSNotice of Interim Results
26th Sep 20232:50 pmRNSResult of Annual General Meeting
26th Sep 20237:00 amRNSAGM Trading Update
4th Sep 20237:00 amRNSNotice of AGM
31st Aug 20237:00 amRNSInnovative production unit for green hydrogen
29th Aug 202312:43 pmRNSDividend Declaration
24th Aug 20237:00 amRNSFull Year Results
10th Aug 20237:00 amRNSNotice of Full Year Results
14th Jun 20237:00 amRNSDirectorship Change
7th Jun 20237:00 amRNSTFP HYDROGEN ANNOUNCES EXPANSION IN NORTH AMERICA
21st Apr 20235:18 pmRNSDirector/PDMR Shareholding
19th Apr 20237:00 amRNSTrading Update and Overview of Strategy
14th Feb 202312:00 pmRNSDirector/PDMR Shareholding
1st Feb 20237:00 amRNSDirector/PDMR Shareholding
31st Jan 20239:45 amRNSDirector/PDMR Shareholding
2nd Dec 20227:00 amRNSDirector/PDMR Shareholding
18th Nov 20229:48 amRNSDirector/PDMR Shareholding
15th Nov 20227:00 amRNSHalf-year Report
31st Oct 20227:00 amRNSHalf Year Trading Update
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
12th Sep 202211:03 amRNSDirector/PDMR Shareholding
2nd Sep 20224:40 pmRNSSecond Price Monitoring Extn
2nd Sep 20224:35 pmRNSPrice Monitoring Extension
26th Aug 20227:00 amRNSDirector/PDMR Shareholding
10th Aug 20227:00 amRNSDirectorship Change
5th Aug 202211:45 amRNSDirector/PDMR Shareholding
27th Jul 202211:00 amRNSQ1 Trading Update and AGM Statement
19th Jul 20227:00 amRNSDirector/PDMR Shareholding
8th Jul 202210:34 amRNSDirector/PDMR Shareholding
7th Jul 20227:00 amRNSDirector/PDMR Shareholding
23rd Jun 202210:25 amRNSNotice of AGM and Annual Report & Accounts
21st Jun 20227:00 amRNSFinal Results
12th May 202212:01 pmRNSHolding(s) in Company
24th Mar 20227:00 amRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSTrading Update
26th Jan 20222:30 pmRNSDirector/PDMR Shareholding
21st Jan 202212:15 pmRNSDirector/PDMR Shareholding
20th Jan 202210:30 amRNSDirectorate Change
12th Jan 20222:00 pmRNSCorrection to Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.